Home
Scholarly Works
Cancer Risk With Topical Pimecrolimus and...
Conference

Cancer Risk With Topical Pimecrolimus and Tacrolimus For Atopic Dermatitis: Systematic Review and Bayesian Meta-Analysis

Authors

Chu A; Devasenapathy N; Wong M; Srivastava A; Lin C; Ceccacci R; MacDonald M; Chu D; Parameters FTAAJTFOP

Volume

151

Publisher

Elsevier

Publication Date

February 1, 2023

DOI

10.1016/j.jaci.2022.12.602

Conference proceedings

The Journal of Allergy and Clinical Immunology

Issue

2

ISSN

0091-6749

Contact the Experts team